Prophylactic Antibiotics for Suction Curettage in Incomplete Abortion by Ramin, Kirk D. et al.
Infectious Diseases in Obstetrics and Gynecology 2:213-217 (I 995)
(C) 1995 Wiley-Liss, Inc.
Prophylactic Antibiotics for Suction Curettage in
Incomplete Abortion
Kirk D. Ramin, Susan M. Ramin, Patricia G. Hemsell,
Brenda J. Nobles, Molly C. Heard, Vivian B. Johnson,
and David L. Hemsell
Departments of Obstetrics and Gynecology (K.D.R., S.M.R., P.G.H., B.J.N., M.C.H., D.L.H.)
and Pharmacy (V.B.J.), University of Texas Southwestern Medical Center, Parkland Memorial
Hospital, Dallas, TX
ABSTRACT
Objective: The purpose of this study was to investigate the efficacy of 200 mg of prophylactic
doxycycline in preventing pelvic infection after curettage for spontaneous (incomplete) abortion.
Methods:A randomized, prospective, double-blinded study was carried out involving 300 women
with an incomplete abortion who were given either placebo or 200 mg of doxycycline orally 30-60
min prior to curettage. A hematocrit, WBC count, pregnancy test, syphilis serology, Neisseria
gonorrhoeae culture, and MicroTrak (monoclonal antibody test, Syba, San Jose, CA) for Chlamydia
trachomatis were performed. The patients were scheduled for follow-up 2 weeks later. Antibiotic
administration for any reason as well as the postoperative infection rate in these women was
assessed.
Results: Eleven women were excluded from analysis, leaving 289 evaluable. N. gonorrhoeae was
isolated from 6 (2%) women and C. trachomatis from 8 (3%) women, and the syphilis serology was
serofast in 4 (1%) women. Endometritis complicated the procedure in 4 women who received
placebo and in 1 woman who received doxycycline (P 0.22).
Conclusion: Prophylactic doxycycline is not effective in preventing pelvic infection after curettage
for spontaneous (incomplete) abortion. (C) 1995 Wiley-Liss, Inc.
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It is well known that the use of antibiotic prophy-
laxis for women undergoing vaginal hysterectomy
or cesarean delivery reduces the rate of infection
and febrile morbidity following these proce-
dures.
1-5 Controversy exists on the efficacy of pro-
phylactic antibiotics for elective terminations of
pregnancy. Several randomized clinical studies re-
ported that prophylactic antibiotics decreased infec-
tious morbidity following elective curettage abor-
tions by approximately 50%.
6-8 To date, there are
no known published studies addressing the prophy-
lactic use of antibiotics in the clinical setting of
suction curettage for spontaneous incomplete abor-
tion. At our institution, women undergoing suction
curettage for incomplete abortion were commonly
given a 7-10 day course of doxycycline without
documentation of patient benefit. We sought to
evaluate the efficacy of a single dose of prophylactic
doxycycline, compared with placebo, in women un-
dergoing suction curettage for spontaneous incom-
plete abortion and to establish the postoperative
infection rate in these women.
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TABLE I. Demographics of 289 women given 200 mg of doxycycline or placebo before suction curettage for
spontaneous incomplete abortion
Variable
Prophylactic regimen
Doxycycline Placebo
(N 137) (N 152)
Age (years) 25. -+ 7.3
Gravidity 2.7 -+ 1.8
Parity 1.3 -+ 1.5
Previous abortions (spontaneous or induced) 0.5 0.8
Race
African-American 29
Caucasian 24
Mexican-American 79
Other 5
Marital status
Married 64
Single 68
Divorced 4
Unknown
24.7 -+ 6.6
3.0 -+ 1.9
1.4 _+ 1.5
0.7 1.0
(21) 43 (28)
(17) 2m (14)
(SB) B) (SS)
(4) S ()
(47) 82 (54)
(49) 61 (40)
(3) S (3)
() 4 (3)
aMean -+ standard deviation.
bNumber with percent in parentheses.
SUBJECTS AND METHODS
All healthy women presenting to the emergency
room at Parkland Memorial Hospital who were
diagnosed with spontaneous incomplete abortion
were invited to participate in this prospective, dou-
ble-blinded clinical trial and to sign Institutional
Review Board-approved consent forms. The women
were randomized by sealed envelopes to receive
either 1) 200 mg of doxycycline or 2) placebo.
Either doxycycline or placebo was taken orally
30-60 min prior to suction curettage. The exclu-
sion criteria included a history of allergic reactions
to tetracycline or doxycycline, fever (defined as a
temperature >38C), unstable vital signs, a uter-
ine size > 14 weeks, a hematocrit <30%, antibiotic
use within the previous 2 weeks, or any medical
illness such as diabetes mellitus or cardiac or pul-
monary disease.
A medical history was taken, and a complete
physical examination was performed. A pregnancy
test, hemoglobin, hematocrit, WBC count, syphi-
lis serology, Neisseria gonorrhoeae culture, and
MicroTrak (monoclonal antibody test, Syba, San
Jose, CA) for Chlamydia trachomatis were per-
formed. A suction curettage was carried out and the
patient was scheduled for follow-up 2 weeks later.
The clinical diagnosis of endometritis was based on
the following criteria: temperature >38.0C, ab-
dominal pain, tenderness on one or both sides of the
abdomen, uterine tenderness, parametrial tender-
ness elicited upon bimanual examination, and foul-
smelling lochia. Antibiotic administration for any
reason was monitored.
Data were analyzed using the Student’s t-test,
Fisher exact test, chi-squared test, or Mann-Whit-
ney U-test, when appropriate. Significance was de-
fined as P < 0.05.
RESULTS
Between November 1992 and June 1993, 300
women were enrolled. After randomization, the
following women were excluded from analysis: 3
women in whom the curettage was not performed,
6 who had had recent antibiotic use, who did not
receive the assigned study drug, and who under-
went an emergent hysterectomy for uterine perfora-
tion and hemorrhage. Therefore, 11 women were
excluded, leaving 289 (96%) evaluable. The de-
mographics ofthe study population, which are sum-
marized in Table 1, were comparable.
The historical (medical and gynecologic) infor-
mation obtained from these women was also compa-
rable. The estimated gestational age determined by
bimanual examination (9.5 weeks) was 2 weeks less
than the estimated gestational age by last menstrual
period (11.5 weeks) in both groups. No significant
214 INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGYANTIBIOTICS FOR INCOMPLETE ABORTION RAMIN ET AL.
TABLE 2. Laboratory results in 289 women given 200 mg of doxycycline or placebo before suction curettage
for spontaneous incomplete abortion
Prophylactic regimen
Doxycycline Placebo
Variable (N 137) (N 152)
Preoperative WBC count (xl03/mm3) 10.2 -+ 3.3
Hematocrit (%)
Pre-curettage 36.5 -
4.3
Post-curettage 32.5 4.4
Products of conception
Yes 122
No 14
Molar change 0
Specimen lost
10.6 -+ 3.4
(89) 137 (90)
(I O) (7)
(0) (I)
() 3 (2)
aMean +_ standard deviation.
bNumber with percent in parentheses.
differences were identified in the pre- and post-
curettage vital signs. The laboratory results are
summarized in Table 2. There was not a significant
difference in the mean preoperative WBC count or
hematocrit or in blood types. The 25 women with
no chorionic villi on pathologic examination were
followed with serial quantitative human chorionic
gonadotropin values. Two of these women were
subsequently diagnosed with ectopic pregnancies.
The remaining 23 women were felt to have had
complete abortions.
The results of laboratory testing for preexisting
sexually transmitted diseases are summarized in Ta-
ble 3. The presence of existing sexually transmitted
diseases in our study population did not appear to
increase the risk of post-procedureal pelvic infec-
tion. None of the women with chlamydia, gonor-
rhea, or a history of syphilis had infection. One of
the women with N. gonorrhoeae on culture returned
with a cystitis. The women enrolled in this study
were evaluated in regard to those infected vs. those
not infected. Due to the small number of those
infected, no statistical difference was seen in regard
to the parameters previously listed.
The infectious and surgical complications were
examined in the 289 evaluable women. While there
was no significant difference (P 0.45) in regard
to postoperative endometritis, cervicitis, or urinary
tract infections among the groups, more women in
the placebo arm were diagnosed with metritis (4 vs.
1) following the procedure. The only women who
required admission for treatment of infection re-
TABLE 3. Presence (culture or serology) of
selected infections in study patients
N. C.
gonorrhoeae trachomatis Syphilis
Doxycycline (N 137)
Positive 3 2 2
Negative 126 123 135
Unsatisfactory 3
specimen
Not done 5 II
Placebo
Positive 3 6 2
Negative 145 139 149
Unsatisfactory 2 2
specimen
Not done 2 5
aSerofast syphilis.
ceived doxycycline prophylaxis. Nine women were
admitted for medical or surgical complications.
Seven were admitted and observed for acute blood
loss anemia, and of these was transfused. One
woman sustained a laceration of the uterine artery
from the suction curette requiring blood transfu-
sion and hysterectomy. In addition, woman had a
cardiac arrhythmia and another had severe hyper-
tension off medication. One hundred twenty-two
(89%) of the patients who received doxycycline and
137 (90%) of the control patients returned for fol-
low-up. Fifteen patients in each arm failed to re-
turn for follow-up. The medical records on these
30 women were reviewed, and these women were
found to have had either gynecology or family plan-
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ning visits within a year after the abortion. None of
these women reported complications surrounding
the suction curettage.
DISCUSSION
Preventing postoperative infection following abor-
tion has long been the goal of obstetrician-gynecol-
ogists. Between 1975 and 1977, 41 women died
following spontaneous abortion, with 15 (37%) of
these deaths being attributable to sepsis.
9 Reduction
in the size of the bacterial inoculum that enters the
surgical site, alteration of the "culture medium" at
the’surgical site with a decreased capacity for the
growth of pathogenic bacteria, penetration of oper-
ative-site tissues reducing susceptibility to bacterial
invasion, and enhanced killing of phagocytized bac-
teria by WBCs are all possible means by which
prophylactic antimicrobials function.
5
Grimes and colleagues
1 reviewed the prophy-
lactic use of antimicrobials in elective pregnancy
terminations and concluded that "despite the meth-
odological limitations, these studies...support the
hypothesis that systemic prophylactic antibiotics are
effective in lowering morbidity from curettage
abortions by about one half." Calculating the costs
(direct and indirect) of hospitalization due to post-
operative infection, they estimated that prophylaxis
would save $2 million annually. These savings do
not include additional long-term costs associated
with reproductive failure subsequent to pelvic in-
flammatory disease. Park et al.
11 analyzed 26,332
women who underwent suction-curettage abortions
and concluded that prophylactic antibiotics reduced
the rate of febrile complications to about one-third
that of women who received no prophylaxis. In an
era of cost containment, savings of this magnitude
lead many authors to recommend antepartum pro-
phylaxis for abortion.
In a prospective, double-blinded, randomized
trial of 400 mg of metronidazole vs. placebo in
women undergoing elective first-trimester abor-
tions, the postabortal infection rates were 20.4% in
the control group and 3.9% in the treatment group
(P (0.025).
12 A history of pelvic inflammatory
disease was associated with an increased frequency
of infection. Several authors have suggested a ben-
eficial effect of prophylaxis only when selection
criteria are used as opposed to general administra-
tion. These criteria include positive screens for N.
gonorrhoeae, C. trachomatis, Trichomonas vaginalis,
a history of gonorrhea, and multiple sexual part-
13--15 nets.
In the current trial, we evaluated the effect of
200 mg of doxycycline in reducing pelvic infection
following suction curettage for incomplete abor-
tion. The incidence of febrile morbidity following
such a procedure performed in the outpatient set-
ting of a large inner-city hospital was unknown
prior to the completion of this study. Endometritis
occurred in woman in the treatment group com-
pared with 4 women in the control group
(P 0.22). Of the 5 women with pelvic infection,
only (from the treatment arm) was admitted for
treatment of her infection. A power analysis re-
vealed that approximately 700 women would be
needed to achieve significance, provided the cur-
rent trend continued. Prophylactic doxycycline is
not effective in preventing pelvic infection after
curettage for spontaneous (incomplete) abortion.
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